Hepalink Pharmaceuticals-B (02142) and UMOJA BIOPHARMA have entered into an evaluation and licensing agreement.

Zhtng cijng APP xn, h b yyo-B (02142) fb gnggo, bn gngs qunz zgngs nun shngw (szhu) yuxin gngs (nun shngw) y y Umoja Biopharma, Inc. (Umoja Biopharma) dng l pngg y shu qun xiy (xiy), zhzi jing nun shngw de HCAb Harbour Mice pngti h NonaCarFxTM pngti y Umoja Biopharma de VivoVecTM pngti xing jih, gngtng tujn du kun tni CAR-T xbo chnpn ynf. Xiy biozh zhe ling ji gngs y 2024 nin 9 yu jil de zhnl hzu hubn gunx jnyn shnki tuyun.